For the latest updates on our ongoing response to COVID-19, please click here.

                        Gilead Public Health Award in Viral Hepatitis

                        Award Announcement

                        The purpose of the Gilead Public Health Award (GPHA) in Viral Hepatitis is to foster innovative scientific research that will advance knowledge about the prevention, care and treatment of viral hepatitis, and support the career development of early stage researchers from low and middle-income countries (LMICs). Please click here to download the PDF, "GPHA Program Description and Sample Application" which provides program details. Note, however, Gilead will only accept online applications submitted via the grants portal.

                        Selection Criteria

                        Gilead encourages proposals that demonstrate:

                        • Clear alignment with an area of health priority and scientific importance to the LMIC
                        • Relevancy to the applicant’s career objectives
                        • Specific, measurable and realistic objectives and steps required to meet research and career development goals


                        • This award is intended for junior faculty or post-doctoral students who hold an M.D., D.O., Ph.D, or equivalent degree at time of award
                        • Applicants must be employed at an academic or research institution in eligible countries in Africa, Latin America, South and Southeast Asia and certain Commonwealth of Independent States countries (for the full list of eligible countries, download the program document)
                        • Applicants must be a citizen or permanent resident of the nation and/or state where they plan to conduct the research

                        Scientific Focus

                        Applicants can propose an exploratory project and/or an existing funded project that addresses critical areas of research including:

                        • Viral hepatitis prevention, treatment and management
                        • Viral hepatitis and its complications in vulnerable and/or under-researched LMIC populations (children, aging, women, transgendered, drug and alcohol users, etc.)
                        • Viral hepatitis and co-morbidities
                        • Health economics outcomes research related to viral hepatitis
                        • Community-based intervention models across the continuum of care

                        Application Process

                        • Gilead accepts applications on a rolling basis. Gilead will communicate decisions quarterly and announce awards at international or regional meetings and events
                        • Applicants are required to use the online form, available here
                        • Please review the grant Terms and Conditions before submitting an application
                        • Submit questions about the announcement or application process to with subject line of email: GPHA Viral Hepatitis Program

                        Program Specifics

                        • The Award provides financial support to the institution of the junior faculty or post-doctoral student for a two-year period
                        • Funding for the second year is contingent upon submission of a progress report by each researcher and approval by the internal Gilead Review Committee

                        About Gilead Sciences

                        Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

                        GPHA Program Description & Sample Application